AnaptysBio, Inc. (ANAB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 898.14M |
| Enterprise Value | 674.06M |
| P/E Ratio | -76.33 |
| PEG Ratio | 0.21 |
| Price/Sales Ratio | 12.04 |
| Price/Book Ratio | 146.03 |
| Enterprise/Revenue | 12.16 |
| Enterprise/EBITDA | 48.33 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.12 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | -0.08 |
| Return On Equity | 4.43 |
Income Statement
| Revenue | 234.6M |
| Revenue/Share | 8.1 |
| Gross Profit | 232.18M |
| EBITDA | 69.25M |
| Net Income | -13.23M |
| Diluted EPS | -0.46 |
Balance Sheet
| Total Cash | 286.46M |
| Total Cash/Share | 9.98 |
| Total Debt | 277.36M |
| Total Debt/Equity | 21.76 |
| Current Ratio | 7.58 |
| Book Value Per Share | 0.44 |
Price History
| 52-Week Change | 338.38 |
| 52-Week High | 72.36 |
| 52-Week Low | 11.4 |
| Moving Average 50 Days | 58.6 |
| Moving Average 200 Days | 37.19 |
Statistics
| Average Volume | 702,769 |
| Shares Outstanding | 43.12M |
| % Held by Institutions | 152.41 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 3:2 |
| Last Split Date | April 20, 2026 |
AD
